medigraphic.com
ISSN 0188-9796 (Print)

2009, Number 2

<< Back Next >>

Rev Endocrinol Nutr 2009; 17 (2)

Perceptions of the diabetic patient in regards to photocoagulation

Lima GV, Rojas DJA, Ochoa GA, Razo BHDM

Language: Spanish
References: 18
Page: 76-80
PDF size: 83.57 Kb.


ABSTRACT

Introduction and objectives: Treating proliferative diabetic retinopathy (PDR) with photocoagulation efficiently reduces hyperglycemia-induced ischemia and further visual loss. However, some patients may perceive it as the cause of visual loss or as a definitive therapy. With the aid of a questionnaire we identified patients in whom lack of information contributed to these perceptions. Methods: This is a descriptive, cross-sectional, open study. A 20-item questionnaire with information about the illness and its treatment was applied to patients with PDR undergoing photocoagulation between January and June 2008. The proportion of patients that knew the information each item dealt with was identified, as well as the association between items. Educational intervention was considered necessary when at least 25% of the patients were unfamiliar with the item information. Results: 50 patients were evaluated, mean age 60.2 years, 48% females. More than 25% of the patients were unfamiliar with the information related to the origin of their ocular illness and the beneficial effect of treatment, illness recurrence and the possibility of additional treatments; only 28% of the patients knew that photocoagulation does not improve visual function. Conclusions: In 70% of the items related to patient information the content was unknown by more than 25% of the subjects. Three areas of opportunity for success in the ophthalmic treatment were identified: information about the illness for patients and family, adequate medical control and expectations about treatment.


REFERENCES

  1. Fong DS, Aiello LP, Ferris FL, 3rd et al. Diabetic retinopathy. Diabetes Care 2004; 27: 2540-2553.

  2. Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350: 48-58.

  3. Simo R, Hernández C. Advances in the medical treatment of diabetic retinopathy. Diabetes Care 2009; 32: 1556-1562.

  4. American Academy of Ophthalmology. Retina Panel. Diabetic Retinopathy. Preferred practice patterns. 2008.

  5. American Academy of Ophthalmology. retina and vitreous. Basic and clinical science course. San Francisco: American Academy of Ophthalmology; 2004

  6. Photocoagulation therapy for diabetic eye disease. Early Treatment Diabetic Retinopathy Study Research Group. JAMA 1985; 254: 3086.

  7. Ryan S, Hinton D, Schachat A et al. Retina. St. Louis: Mosby-Yearbook; 2008.

  8. Kovacic Z, Ivanisevic M, Karelovic D. [The loss of visual field after proliferative diabetic retinopathy treatment with two different techniques of panretinal photocoagulation]. Acta Med Croatica 2007; 61: 149-152.

  9. Shimura M, Yasuda K, Nakazawa T et al. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 2003; 110: 2386-2394.

  10. Graue WE. Retinopatía diabética. En: Graw-Hill M, ed. Oftalmología en la práctica de la medicina general. México; 2009: 198.

  11. Hartnett ME, Key IJ, Loyacano NM et al. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol 2005; 123: 387-391.

  12. Leñero OL. Investigación de la familia en México: presentación y avance de resultados de una Encuesta Nacional. México: Instituto Mexicano de Estudios Sociales; 1971.

  13. Latorre PJM, Beneit MPJ. La enfermedad crónica. Psicología de la salud: aportaciones para los profesionales de la salud. Buenos Aires: Lumen; 1994: 225-234

  14. Estrada IL. Ciclo vital de la familia. México: Grijalbo; 1994.

  15. Muñoz B, O’Leary M, Fonseca-Becker F et al. Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes. Arch Ophthalmol 2008; 126: 968-974

  16. Mozaffarieh M, Benesch T, Sacu S et al. Photocoagulation for diabetic retinopathy: determinants of patient satisfaction and the patient-provider relationship. Acta Ophthalmol Scand 2005; 83: 316-321.

  17. Alcántara JA. Cómo educar las actitudes. Barcelona: Ediciones CEAC; 1992.

  18. Sharma S, Oliver-Fernández A, Liu W et al. The impact of diabetic retinopathy on health-related quality of life. Curr Opin Ophthalmol 2005; 16: 155-159.




2020     |     www.medigraphic.com